Emirates News Agency – Dubai to host Middle East’s first precision medicine trade show and summit
DUBAI, 21st May, 2022 (WAM) — Next month Dubai will host the Middle East’s first exhibition and summit dedicated to the field of precision medicine (PM) driven by digital technology. More than 70 international experts, thought leaders, and medical pioneers from Asia, the Middle East, Europe, and the United States are set to provide incisive insights into the new methodology that is taking healthcare from a “one-size-fits-all” approach to a targeted and personalized approach. , approach.
The recently launched Precision Medicine Expo and Summit, under the patronage of Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and Coexistence and President of the UAE Genetic Diseases Association, will take place in the Conrad Hotel from May 24 to 25, where health professionals meet. To learn the latest PM techniques and innovations, aspiring health tech startups will pitch funding requests to a panel of investors at the co-located groundbreaking Emerge GHI event.
The new event launches come as global data and insights firm Netscribes forecasts the precision medicine market in the Middle East and Africa to grow at a compound annual growth rate of 9.96% for reach $2.51 billion in revenue by 2023.
“The integration of precision medicine into general healthcare settings gives patients with genetic diseases a lot of optimism. Personalized medicine is certainly transforming the healthcare ecosystem for the better, thanks to digitization and a corpus of rapidly growing knowledge that is redefining the way we perceive the very nature of the origins and development of life-threatening diseases. Precision medicine will help us better understand the role of genetics, provide a tailored health management solution for each individual and to reduce the burden of not only genetic disorders but also other rare long-term diseases,” said Dr. Maryam Matar, Founder and President of the UAE Genetic Disease Association.
David Stradling, event director, said: “GCC healthcare providers have already entered the PM space, which is expected to grow 11% per year through 2026 to reach a value of $142 billion. worldwide, with the Mohammed Bin Rashid University of Medicine and Health Sciences in Dubai (MBRU) and the King Faisal Specialist Hospital and Research Center in Saudi Arabia having established centers for biomedical and genomics research and d Others Who Should Follow At the Precision Medicine Summit, healthcare providers, academic scientists and industry experts will have a unique opportunity to share knowledge, discuss challenges and opportunities.”
Speaking ahead of the event, Dr Younis Kazim, CEO of Dubai Healthcare Corporation at Dubai Health Authority, said: “Through the use of technological developments such as artificial intelligence and machine learning, medical Accuracy allows physicians and researchers to accurately predict which treatment and prevention methods for a certain disease will work in which groups of patients. In addition to helping to strengthen the overall development of health technologies in the UAE, we are optimistic that the event will have a significant impact on the way we treat diseases – ultimately leading to better, and more personalized treatment programs. profitable.”
Alongside the Precision Medicine Expo and Summit is the groundbreaking EMERGE GHI Investment Forum, which will be a hotbed of innovation where budding health tech startups will interact with potential investors. Speaking ahead of the Emerge Summit, GluCare.Health, the world’s first fully vertically integrated digital therapy platform to use continuous monitoring of personal health data.
“The Emerge Investment Forum is an ideal springboard to showcase our expertise, advanced solutions, and phenomenal results,” said Ali Hashemi, co-founder and president of GluCare.Health. “The healthcare landscape in the region is changing at a rapid pace with a growing need for value-based and results-driven solutions available to both operators and patients. Diabetes having recently moved from a epidemic to pandemic in the region, we look to the event as a way to discover new partnerships that help us improve and reinvent diabetes care and ensure our platform is accessible to as many patients as possible. possible. “